 | • レポートコード：GIR-107A14254 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヘプシジンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヘプシジンの種類別市場規模（DS-79182026、M-009、PRS-080、PTG-300、その他）、用途別市場規模（急性炎症、貧血、鉄欠乏性貧血、鎌状赤血球症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヘプシジンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Daiichi Sankyo Co Ltd、Pieris Pharmaceuticals Inc、Protagonist Therapeutics Inc、Noxxon Pharma AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：DS-79182026、M-009、PRS-080、PTG-300、その他 ・用途別分析2016年-2026年：急性炎症、貧血、鉄欠乏性貧血、鎌状赤血球症、その他 ・ヘプシジンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヘプシジンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヘプシジンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヘプシジンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヘプシジンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hepcidin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Hepcidin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Hepcidin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Hepcidin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DS-79182026
M-009
PRS-080
PTG-300
Others
Market segment by Application can be divided into
Acute Inflammation
Anemia
Iron Deficiency Anemia
Sickle Cell Disease
Others
The key market players for global Hepcidin market are listed below:
Daiichi Sankyo Co Ltd
Pieris Pharmaceuticals Inc
Protagonist Therapeutics Inc
Noxxon Pharma AG
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Hepcidin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepcidin, with price, sales, revenue and global market share of Hepcidin from 2019 to 2021.
Chapter 3, the Hepcidin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepcidin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hepcidin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Hepcidin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hepcidin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hepcidin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 DS-79182026
1.2.3 M-009
1.2.4 PRS-080
1.2.5 PTG-300
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Hepcidin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Acute Inflammation
1.3.3 Anemia
1.3.4 Iron Deficiency Anemia
1.3.5 Sickle Cell Disease
1.3.6 Others
1.4 Global Hepcidin Market Size & Forecast
1.4.1 Global Hepcidin Sales in Value (2016-2026))
1.4.2 Global Hepcidin Sales in Volume (2016-2026)
1.4.3 Global Hepcidin Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Hepcidin Production Capacity Analysis
1.5.1 Global Hepcidin Total Production Capacity (2016-2026)
1.5.2 Global Hepcidin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hepcidin Market Drivers
1.6.2 Hepcidin Market Restraints
1.6.3 Hepcidin Trends Analysis
2 Manufacturers Profiles
2.1 Daiichi Sankyo Co Ltd
2.1.1 Daiichi Sankyo Co Ltd Details
2.1.2 Daiichi Sankyo Co Ltd Major Business
2.1.3 Daiichi Sankyo Co Ltd Hepcidin Product and Services
2.1.4 Daiichi Sankyo Co Ltd Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pieris Pharmaceuticals Inc
2.2.1 Pieris Pharmaceuticals Inc Details
2.2.2 Pieris Pharmaceuticals Inc Major Business
2.2.3 Pieris Pharmaceuticals Inc Hepcidin Product and Services
2.2.4 Pieris Pharmaceuticals Inc Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Protagonist Therapeutics Inc
2.3.1 Protagonist Therapeutics Inc Details
2.3.2 Protagonist Therapeutics Inc Major Business
2.3.3 Protagonist Therapeutics Inc Hepcidin Product and Services
2.3.4 Protagonist Therapeutics Inc Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Noxxon Pharma AG
2.4.1 Noxxon Pharma AG Details
2.4.2 Noxxon Pharma AG Major Business
2.4.3 Noxxon Pharma AG Hepcidin Product and Services
2.4.4 Noxxon Pharma AG Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Hepcidin Sales by Manufacturer
3.1 Global Hepcidin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hepcidin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hepcidin
3.4 Market Concentration Rate
3.4.1 Top 3 Hepcidin Manufacturer Market Share
3.4.2 Top 6 Hepcidin Manufacturer Market Share
3.5 Global Hepcidin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hepcidin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hepcidin Market Size by Region
4.1.1 Global Hepcidin Sales in Volume by Region (2016-2026)
4.1.2 Global Hepcidin Revenue by Region (2016-2026)
4.2 North America Hepcidin Revenue (2016-2026)
4.3 Europe Hepcidin Revenue (2016-2026)
4.4 Asia-Pacific Hepcidin Revenue (2016-2026)
4.5 South America Hepcidin Revenue (2016-2026)
4.6 Middle East and Africa Hepcidin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hepcidin Sales in Volume by Type (2016-2026)
5.2 Global Hepcidin Revenue by Type (2016-2026)
5.3 Global Hepcidin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hepcidin Sales in Volume by Application (2016-2026)
6.2 Global Hepcidin Revenue by Application (2016-2026)
6.3 Global Hepcidin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hepcidin Sales by Type (2016-2026)
7.2 North America Hepcidin Sales by Application (2016-2026)
7.3 North America Hepcidin Market Size by Country
7.3.1 North America Hepcidin Sales in Volume by Country (2016-2026)
7.3.2 North America Hepcidin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hepcidin Sales by Type (2016-2026)
8.2 Europe Hepcidin Sales by Application (2016-2026)
8.3 Europe Hepcidin Market Size by Country
8.3.1 Europe Hepcidin Sales in Volume by Country (2016-2026)
8.3.2 Europe Hepcidin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hepcidin Sales by Type (2016-2026)
9.2 Asia-Pacific Hepcidin Sales by Application (2016-2026)
9.3 Asia-Pacific Hepcidin Market Size by Region
9.3.1 Asia-Pacific Hepcidin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hepcidin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hepcidin Sales by Type (2016-2026)
10.2 South America Hepcidin Sales by Application (2016-2026)
10.3 South America Hepcidin Market Size by Country
10.3.1 South America Hepcidin Sales in Volume by Country (2016-2026)
10.3.2 South America Hepcidin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hepcidin Sales by Type (2016-2026)
11.2 Middle East & Africa Hepcidin Sales by Application (2016-2026)
11.3 Middle East & Africa Hepcidin Market Size by Country
11.3.1 Middle East & Africa Hepcidin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hepcidin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hepcidin Typical Distributors
12.3 Hepcidin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Hepcidin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hepcidin Revenue by Application, (USD Million), 2021-2026
Table 3. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Co Ltd Major Business
Table 5. Daiichi Sankyo Co Ltd Hepcidin Product and Services
Table 6. Daiichi Sankyo Co Ltd Hepcidin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pieris Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pieris Pharmaceuticals Inc Major Business
Table 9. Pieris Pharmaceuticals Inc Hepcidin Product and Services
Table 10. Pieris Pharmaceuticals Inc Hepcidin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Protagonist Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 12. Protagonist Therapeutics Inc Major Business
Table 13. Protagonist Therapeutics Inc Hepcidin Product and Services
Table 14. Protagonist Therapeutics Inc Hepcidin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Noxxon Pharma AG Basic Information, Manufacturing Base and Competitors
Table 16. Noxxon Pharma AG Major Business
Table 17. Noxxon Pharma AG Hepcidin Product and Services
Table 18. Noxxon Pharma AG Hepcidin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Hepcidin Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 20. Global Hepcidin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Hepcidin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Hepcidin Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 23. Head Office and Hepcidin Production Site of Key Manufacturer
Table 24. Hepcidin New Entrant and Capacity Expansion Plans
Table 25. Hepcidin Mergers & Acquisitions in the Past Five Years
Table 26. Global Hepcidin Sales by Region (2016-2021e) & (K Pcs)
Table 27. Global Hepcidin Sales by Region (2021-2026) & (K Pcs)
Table 28. Global Hepcidin Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Hepcidin Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Hepcidin Sales by Type (2016-2021e) & (K Pcs)
Table 31. Global Hepcidin Sales by Type (2021-2026) & (K Pcs)
Table 32. Global Hepcidin Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Hepcidin Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Hepcidin Price by Type (2016-2021e) & (USD/Pcs)
Table 35. Global Hepcidin Price by Type (2021-2026) & (USD/Pcs)
Table 36. Global Hepcidin Sales by Application (2016-2021e) & (K Pcs)
Table 37. Global Hepcidin Sales by Application (2021-2026) & (K Pcs)
Table 38. Global Hepcidin Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Hepcidin Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Hepcidin Price by Application (2016-2021e) & (USD/Pcs)
Table 41. Global Hepcidin Price by Application (2021-2026) & (USD/Pcs)
Table 42. North America Hepcidin Sales by Country (2016-2021e) & (K Pcs)
Table 43. North America Hepcidin Sales by Country (2021-2026) & (K Pcs)
Table 44. North America Hepcidin Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Hepcidin Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Hepcidin Sales by Type (2016-2021e) & (K Pcs)
Table 47. North America Hepcidin Sales by Type (2021-2026) & (K Pcs)
Table 48. North America Hepcidin Sales by Application (2016-2021e) & (K Pcs)
Table 49. North America Hepcidin Sales by Application (2021-2026) & (K Pcs)
Table 50. Europe Hepcidin Sales by Country (2016-2021e) & (K Pcs)
Table 51. Europe Hepcidin Sales by Country (2021-2026) & (K Pcs)
Table 52. Europe Hepcidin Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Hepcidin Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Hepcidin Sales by Type (2016-2021e) & (K Pcs)
Table 55. Europe Hepcidin Sales by Type (2021-2026) & (K Pcs)
Table 56. Europe Hepcidin Sales by Application (2016-2021e) & (K Pcs)
Table 57. Europe Hepcidin Sales by Application (2021-2026) & (K Pcs)
Table 58. Asia-Pacific Hepcidin Sales by Region (2016-2021e) & (K Pcs)
Table 59. Asia-Pacific Hepcidin Sales by Region (2021-2026) & (K Pcs)
Table 60. Asia-Pacific Hepcidin Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Hepcidin Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Hepcidin Sales by Type (2016-2021e) & (K Pcs)
Table 63. Asia-Pacific Hepcidin Sales by Type (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Hepcidin Sales by Application (2016-2021e) & (K Pcs)
Table 65. Asia-Pacific Hepcidin Sales by Application (2021-2026) & (K Pcs)
Table 66. South America Hepcidin Sales by Country (2016-2021e) & (K Pcs)
Table 67. South America Hepcidin Sales by Country (2021-2026) & (K Pcs)
Table 68. South America Hepcidin Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Hepcidin Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Hepcidin Sales by Type (2016-2021e) & (K Pcs)
Table 71. South America Hepcidin Sales by Type (2021-2026) & (K Pcs)
Table 72. South America Hepcidin Sales by Application (2016-2021e) & (K Pcs)
Table 73. South America Hepcidin Sales by Application (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Hepcidin Sales by Country (2016-2021e) & (K Pcs)
Table 75. Middle East & Africa Hepcidin Sales by Country (2021-2026) & (K Pcs)
Table 76. Middle East & Africa Hepcidin Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Hepcidin Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Hepcidin Sales by Type (2016-2021e) & (K Pcs)
Table 79. Middle East & Africa Hepcidin Sales by Type (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Hepcidin Sales by Application (2016-2021e) & (K Pcs)
Table 81. Middle East & Africa Hepcidin Sales by Application (2021-2026) & (K Pcs)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Hepcidin Typical Distributors
Table 85. Hepcidin Typical Customers
List of Figures
Figure 1. Hepcidin Picture
Figure 2. Global Hepcidin Sales Market Share by Type in 2020
Figure 3. DS-79182026
Figure 4. M-009
Figure 5. PRS-080
Figure 6. PTG-300
Figure 7. Others
Figure 8. Global Hepcidin Sales Market Share by Application in 2020
Figure 9. Acute Inflammation
Figure 10. Anemia
Figure 11. Iron Deficiency Anemia
Figure 12. Sickle Cell Disease
Figure 13. Others
Figure 14. Global Hepcidin Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Hepcidin Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Hepcidin Sales (2016-2026) & (K Pcs)
Figure 17. Global Hepcidin Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Hepcidin Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Hepcidin Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Hepcidin Market Drivers
Figure 21. Hepcidin Market Restraints
Figure 22. Hepcidin Market Trends
Figure 23. Global Hepcidin Sales Market Share by Manufacturer in 2020
Figure 24. Global Hepcidin Revenue Market Share by Manufacturer in 2020
Figure 25. Hepcidin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Hepcidin Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Hepcidin Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Hepcidin Sales Market Share by Region (2016-2026)
Figure 29. Global Hepcidin Revenue Market Share by Region (2016-2026)
Figure 30. North America Hepcidin Revenue (2016-2026) & (USD Million)
Figure 31. Europe Hepcidin Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Hepcidin Revenue (2016-2026) & (USD Million)
Figure 33. South America Hepcidin Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Hepcidin Revenue (2016-2026) & (USD Million)
Figure 35. Global Hepcidin Sales Market Share by Type (2016-2026)
Figure 36. Global Hepcidin Revenue Market Share by Type (2016-2026)
Figure 37. Global Hepcidin Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Hepcidin Sales Market Share by Application (2016-2026)
Figure 39. Global Hepcidin Revenue Market Share by Application (2016-2026)
Figure 40. Global Hepcidin Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Hepcidin Sales Market Share by Type (2016-2026)
Figure 42. North America Hepcidin Sales Market Share by Application (2016-2026)
Figure 43. North America Hepcidin Sales Market Share by Country (2016-2026)
Figure 44. North America Hepcidin Revenue Market Share by Country (2016-2026)
Figure 45. United States Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Hepcidin Sales Market Share by Type (2016-2026)
Figure 49. Europe Hepcidin Sales Market Share by Application (2016-2026)
Figure 50. Europe Hepcidin Sales Market Share by Country (2016-2026)
Figure 51. Europe Hepcidin Revenue Market Share by Country (2016-2026)
Figure 52. Germany Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Hepcidin Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Hepcidin Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Hepcidin Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Hepcidin Revenue Market Share by Region (2016-2026)
Figure 61. China Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Hepcidin Sales Market Share by Type (2016-2026)
Figure 68. South America Hepcidin Sales Market Share by Application (2016-2026)
Figure 69. South America Hepcidin Sales Market Share by Country (2016-2026)
Figure 70. South America Hepcidin Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Hepcidin Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Hepcidin Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Hepcidin Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Hepcidin Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Hepcidin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のファンコニ貧血治療薬市場 2021：企業別、地域別、種類・用途別 The Fanconi Anemia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界の鎌状赤血球症治療薬市場 2021：企業別、地域別、種類・用途別 The Sickle Cell Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の腎性貧血治療市場 2021：企業別、地域別、種類・用途別 The Renal Anemia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の貧血治療市場 2021：企業別、地域別、種類・用途別 The Anemia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の自己免疫性溶血性貧血治療薬市場 2021：企業別、地域別、種類・用途別 The Autoimmune Hemolytic Anemia Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…